STOCKHOLM, SWEDEN ( - Presented by Michael Stöckle,1 Thomas Flaig,2 Carsten H. Ohlmann,1 Howard I. Scher,3 Johann S. de Bono,4 Dana E. Rathkopf,3 Charles J. Ryan,5 Thian Kheoh,6 Jinhui Li,7 Mary B. Todd,8 Thomas W. Griffin,6 Arturo Molina,9 and Karim Fizazi10 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

Abiraterone-EAU-Stockle-poster thumb

1Saarland University, Homburg/Saar, Germany; 2University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, CO, USA; 3Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA; 4The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK; 5Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA; 6Janssen Research & Development, Los Angeles, CA, USA; 7Janssen Research & Development, Raritan, NJ, USA; 8Janssen Global Services, Raritan, NJ, USA; 9Janssen Research & Development, Menlo Park, CA, USA; 10Institut Gustave Roussy, University of Paris Sud, Villejuif, France

Click HERE to read an exclusive report by a UroToday medical writer


Upcoming urology industry events
April 27-29, 2018 / European Society for Medical Oncology Update for Practising Oncologists
European Society for Medical Oncology Update for Practising Oncologists
May 14, 2018 / InterContinental Mark Hopkins Hotel
SITC Cancer Immune Responsiveness Workshop
May 16-17, 2018 / InterContinental Mark Hopkins Hotel
SITC Immuno-Oncology Biomarkers: State of the Art Workshop
May 17, 2018 / Moscone Convention Center North/South, San Francisco, CA
SAU 2018 Annual Meeting at the AUA
Print publications focusing on urological cancer treatments through original commentary & articles

Everyday Urology™ - Oncology Insights

From the Editor

Prostate Cancer and Prostatic Diseases

From the Editor